Gilead has outlined its plans to develop and ramp up production of its remdesivir COVID-19 drug, with CEO Daniel O’Day pledging to ensure it is affordable after phase 3 results showed it ...

Here are the full details: As Minneapolis lays out its summer public safety plans, the city’s violence interrupter groups are challenging new requirements in their proposed contracts.